The Bourbon Friday Show

The Bourbon Friday Show with Dr. Chris Ho from Drug Design Methodologies

On this episode of the Bourbon Friday Show, we had the opportunity to talk with Dr. Chris Ho, Owner and CSO of Drug Design Methodologies.
The Bourbon Friday Show

The Bourbon Friday Show with Charlie Walch from Pluton Biosciences

On this episode of the Bourbon Friday Show, we had the opportunity to talk with Charlie Walch, CEO of Pluton Biosciences.Looking for Good Bugs There...

Pluton Biosciences Successfully Raises $98,000 via Nvsted Regulation Crowdfunding Platform

"If you know about Georges Seurat, the french painter who did the 'dot' paintings, we're kind of making a pointillist painting. Each time we complete a microbe discovery it's like adding a dot to the overall picture, and each dot represents a big data play," Charlie Walch, CEO Pluton Biosciences

Crowdfunding Microbes that Eat Mosquito Larvae to Slow Spread of Disease is Latest Campaign...

St. Louis' regional crowdfunding platform adds two new campaigns in 2019, looking for investments in Pluton Biosciences and CAD Trailer Designs.

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

The BioGenerator backed startup sees the largest Series C venture round raised by a St. Louis bioscience company.

St. Louis Has “Agglomeration” In AgTech, According To A Brookings Report, And That’s A...

A report from the Brookings Institution looks at regional economic strategies surrounding industry clusters, and highlights the work of BioSTL, the Donald Danforth Plant Science Center, and the St. Louis Economic Development Partnership, as examples of organizations that are currently getting it right.

GlobalSTL Attracts International Healthcare Innovators by Focusing in on St. Louis Strengths

Thirteen Israeli and Irish companies are working to launch business deals with St. Louis healthcare systems and corporations following the inaugural GlobalSTL Health Innovation Summit.
NRGene

NRGene Is Racing Against Time to Solve Hunger

After moving to St. Louis several months ago, the St. Louis Mosaic Project helped founders settle in St. Louis and build connections."We need to...
Kaiima

Israeli AgTech Startup Kaiima is Blooming in St. Louis

"Kaiima" is a Hebrew word that means "sustainable" or "long-lasting." For Kaiima-the-company, the name reflects its commitment to developing agricultural solutions for growers to improve their crop productivity in a sustainable way. Meet the Israel-based company that has been growing its US operations rapidly out of the Helix Center in St. Louis County.

Meet Bill Schmidt: Managing Partner at Cultivation Capital Life Sciences Fund

As Managing Partner of the Life Sciences Fund at Cultivation Capital, Bill Schmidt is currently focused on the venture capital firm's Life Sciences Fund II. He's dedicated to helping life sciences entrepreneurs take their companies to the next level–and the good news for founders is, he's done it himself. We sat down with Schmidt to hear how he got his start as a founder, and now investor, in St. Louis.
Ginger Imster

Ginger Imster on Diversity in Tech, Making St. Louis a Startup Magnet & Upcoming...

Imster has been tasked with promoting our region to startups in the US and around the world. We sat down with her to catch up on the Partnership's upcoming initiatives around innovation and entrepreneurship.
Dollar sign fundraising

12 Fundraising Tips for BioTech companies from Cultivation Capital’s Life Sciences Fund

Bill Schmidt, Managing Partner of Cultivation Capital's Life Science Fund, shares tips for BioTech companies focused on fundraising.

Cortex-based Affigen Announces $17 million Series A Led by Black Beret Life Sciences

Affigen, a biotechnology company based in the Cortex Innovation Community that develops therapeutics targeting cell lineage-specific tumor proteins, today announced the closing of a $17...
Adarza BioSystems

Adarza BioSystems Closes on $17 Million – What’s Next for the Life Science Startup

On January 19, startup Adarza BioSystems, Inc, based in St. Louis and Rochester, New York, closed on $17 Million in Series C financing. Here's what the life science company is focused on next.

Founder Series: Joseph Monahan of Confluence

When Pfizer left St. Louis in 2010, A small team of ex-Pfizer scientists with strong ideas for a new strategic approach to drug discovery research...

How Arch Grant’s Recipient Hemadvance Attracted its Startup Dream Team

As the leading cause of mortality in the world—responsible for more than 30 percent of global deaths according to the World Health Organization—the magnitude...

That’s Life (Sciences)

We examine St. Louis' life sciences startup scene: a hotbed of innovation, growth and promise.
Bio STL Global STL EQ

International Affair

How BioSTL's team is building a relationship with Israel's startups to grow St. Louis' ecosystem.

Disrupting Infection with Nanotechnology and Tom Cohen

Tom Cohen is founder of Nanopore Diagnostics, a St. Louis life science startup that's part of a new wave of companies bringing nanotechnology tools...

This Biomedical Startup is Taking on Life-Threatening Fibrotic Disease

There is a highly progressive and life threatening disease that affects approximately 130,000 people in the United States. It’s worse than many cancers. According...

What’s Next For St. Louis With Dr. Cheryl Watkins-Moore

As the St. Louis startup community continues to grow, the voices and concerns of its founders, grass roots organizers and support organizations need to...

Disrupting Genomics with Jarret Glasscock

After leaving the world-renowned Genome Center at Washington University in St. Louis, Jarret Glasscock co-founded Cofactor Genomics, which has been at the forefront of sequencing and analysis of DNA for researchers worldwide.

Day 1 with Sq1: Lessons for First-Time Entrepreneurs

So you wanna be an entrepreneur? Sq1 is here to help you.

How St. Louis Startup Pulse Therapeutics Attracted Success

Pulse Therapeutics was founded in 2008 in St. Louis. The life science startup patented a technology to combat blood clots using the power of magnets. According to CEO, Sean Morris, a company needs two things to succeed in the startup environment.

From NY To STL: Why This Life-Science Company Relocated To The Midwest

The operating principle of St. Louis' startup community is simple: Bring in companies looking to grow, and empower them to do so